Toggle Main Menu Toggle Search

Open Access padlockePrints

PD-1 receptor deficiency enhances CD30+ Treg cell function in melanoma

Lookup NU author(s): Dr Jing Xuan LimORCiD, Tegan McTaggart, Dr Katie SmithORCiD, Dr Gill HulmeORCiD, Dr Stephanie Laba, Dr Yi NgORCiD, Dr Amelia Williams, Raf Hussain, Dr Jonathan Coxhead, Dr Ioana Cosgarea, Dr Catherine ArdenORCiD, Dr Jérémie NsengimanaORCiD, Professor Penny LovatORCiD, Dr Shoba AmarnathORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2025.Regulatory T (Treg) cells are vital for immune suppression. The role of the coreceptor programmed cell death 1 receptor (PD-1) in Treg cell function is controversial. Here, we demonstrate that PD-1 deficiency enhances the function of Treg cells through expression of a compensatory network of coinhibitory receptors. CD30 has a central role within this network, driving the Treg cell suppressive function within the tumor microenvironment. Mechanistically, PD-1 deficiency enhances STAT5 signaling in Treg cells, which induces CD30 expression. These data indicate a role for PD-1 as a checkpoint that negatively controls CD30 expression in Treg cells to limit their suppressive function. Understanding the functional changes that PD-1 has on Treg cells might enable combination therapies with better treatment outcomes in cancer.


Publication metadata

Author(s): Lim JX, McTaggart T, Jung SK, Smith KJ, Hulme G, Laba S, Ng YQ, Williams A, Hussain R, Coxhead J, Cosgarea I, Arden C, Nsengimana J, Lovat P, Anderson G, Sun H-W, Laurence A, Amarnath S

Publication type: Article

Publication status: Published

Journal: Nature Immunology

Year: 2025

Pages: epub ahead of print

Online publication date: 02/06/2025

Acceptance date: 25/04/2025

Date deposited: 16/06/2025

ISSN (print): 1529-2908

ISSN (electronic): 1529-2916

Publisher: Nature Research

URL: https://doi.org/10.1038/s41590-025-02172-0

DOI: 10.1038/s41590-025-02172-0


Altmetrics

Altmetrics provided by Altmetric


Share